Literature DB >> 21500578

[Effect of platelet-rich plasma on synovitis of rabbit knee].

Ji Liu1, Ting Yuan, Changqing Zhang.   

Abstract

OBJECTIVE: Platelet-rich plasma (PRP) can promote the repair of soft tissue, wound, and bone defect. To investigate the effect of PRP on synovitis by establishing papain-induced osteoarthritis model of rabbit knee and interfering with PRP.
METHODS: Twenty healthy 6-month-old rabbits (male or female, weighing 2.5-3.5 kg) were randomly divided into the experimental group (n = 10) and the control group (n = 10). The whole blood (10 mL) was extracted from the central aural artery and PRP was prepared with the Landesberg's method. Meanwhile, the platelet derived growth factor (PDGF), transforming growth factor (TGF), and vascular endothelial growth factor (VEGF) concentrations in the circulating blood and PRP were measured. The 4% papain solution (0.3 mL) was injected into the knee joint cavity to establish the osteoarthritis model. After that, PRP (0.3 mL) was injected into the knee joints every week for 10 weeks in the experimental group, while normal saline of the same volume in the control group. At 2nd, 4th, 6th, 8th, and 10th weeks after the first injection, the erythrocyte sedimentation rate (ESR) and interleukin 1beta (IL-1beta) concentrations in the whole blood were tested, and the histological changes of the synovium were observed by HE staining and the Mankin scores were made.
RESULTS: The blood cell counting showed that the platelet concentration of PRP was 6.8 times as that of the circulating blood. PDGF, TGF-beta, and VEGF were 5, 8, and 7 times as those of the circulating blood, showing significant differences (P < 0.05). All animals survived to the end of experiment. There were significant differences in the ESR at 2nd, 6th, 8th, and 10th weeks and in the IL-1beta at 4th, 6th, 8th, and 10th weeks between 2 groups (P < 0.05). In the control group, the synovium was edematous and thickened with fibrous effusion and pannus on surface; in the experimental group, the effusion of the synovium was decreased and less congestion and edema were observed at the 2nd week; the synovium was observed to be a bit thickened without obvious edema, with slight amount of yellowish joint fluid on surface and no conglutination at the 10th weeks. There were significant differences in the Mankin score at 4th, 6th, 8th, and 10th weeks (P < 0.05) between 2 groups.
CONCLUSION: PRP is beneficial to the alleviation of synovitis induced by papain according to restoring the damaged tissue and depressing the inflammatory factors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21500578

Source DB:  PubMed          Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi        ISSN: 1002-1892


  4 in total

1.  Chondroprotective effects of multiple PRP injections in osteoarthritis by apoptosis regulation and increased aggrecan synthesis- Immunohistochemistry based Guinea pig study.

Authors:  Sandeep Patel; Narayan Prasad Mishra; Devendra Kumar Chouhan; Uma Nahar; Mandeep S Dhillon
Journal:  J Clin Orthop Trauma       Date:  2022-01-11

2.  Platelet-Rich Plasma Is More Than Placebo-Rich Plasma for Early Osteoarthritis Knee.

Authors:  Tungish Bansal; Sandeep Patel
Journal:  Cartilage       Date:  2021-01-19       Impact factor: 3.117

3.  Xenotransplantation of human dental pulp stem cells in platelet-rich plasma for the treatment of full-thickness articular cartilage defects in a rabbit model.

Authors:  Ricardo Hideki Yanasse; Roger William De Lábio; Leonardo Marques; Josianne Tomazini Fukasawa; Rosimeire Segato; Angela Kinoshita; Mariza Akemi Matsumoto; Sergio Luis Felisbino; Bruno Solano; Ricardo Ribeiro Dos Santos; Spencer Luiz Marques Payão
Journal:  Exp Ther Med       Date:  2019-04-17       Impact factor: 2.447

4.  The effect of intra-articular allogenic platelet rich plasma in Dunkin-Hartley guinea pig model of knee osteoarthritis.

Authors:  Himanshu Kanwat; Dhillon Mandeep Singh; Chouhan Devendra Kumar; Bhatia Alka; Saikia Biman; Hooda Aman
Journal:  Muscles Ligaments Tendons J       Date:  2018-01-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.